Healthcare, Pharmaceuticals, and Innovation by Viatris

18.22
0.7650
4.38 %
Daily range
Weekly range
  • Ciaran Ryan
  • 06.08.2026
Viatris shares fall nearly 3% as profit-taking and fading momentum pressure the stock
Viatris Inc. (VTRS) fell 2.97% as profit-taking and a loss of early upside momentum weighed on the shares, even as better-than-expected sales and an improved full-year outlook were reported. The ...
  • Sholanke Dele
  • 06.08.2026
Viatris stock holds firm above $17.50 support despite slight daily decline
Viatris reported its second-quarter financial results, according to a post from the company. At the same time, Viatris stock edges lower on the day, trading at $17.65.Viatris Inc used its official ...
  • Dan Blystone
  • 30.07.2026
Viatris edges higher to $17.94 as Q2 2026 call scheduled, Viatris Inc. announces
Viatris will hold its Q2 2026 conference call on August 6 at 8:30 a.m. ET.Registration for the webcast is available online. The company shared the registration link in its ...
  • Ezequiel Gomes
  • 29.07.2026
Viatris stock gains 1.25% as FDA approves new contraceptive patch, Viatris Inc reports
Viatris announced that the U.S. FDA has approved its new combined hormonal contraceptive patch with low-dose estrogen.The company described the product as a non-invasive, once-weekly patch. ...
  • Parshwa Turakhiya
  • 29.06.2026
Viatris stock holds steady as originator medicines receive Vietnam marketing authorization
Viatris (VTRS) stock is trading at $16.19 after a modest daily decline. The price remains above its key moving averages, reflecting resilience despite the mild ...